Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome

119Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In a double-blind placebo-controlled trial, gamma-hydroxybutyric acid (GHB) (25 mg/kg orally) suppressed most of the withdrawal symptomatology in 14 heroin addicts and 13 methadone-maintained subjects. The GHB effect was prompt (within 15 minutes) and persisted for between 2 and 3 hours. Subsequently, the same patients received GHB in an open study every 2 to 4 hours for the first 2 days and 4 to 6 hours for the following 6 days: most abstinence signs and symptoms remained suppressed and patients reported felling well. Urine analysis failed to detect any presence of opiate metabolites. No withdrawal symptomatology recurred after 8 days of treatment when GHB was suspended, and patients were challenged with an intravenous injection of 0.4 mg naloxone. The results indicate that GHB may be useful in the management of opiate withdrawal. © 1993, American College of Neuropsychopharmacology. All rights reserved.

References Powered by Scopus

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

4110Citations
N/AReaders
Get full text

CLONIDINE BLOCKS ACUTE OPIATE-WITHDRAWAL SYMPTOMS

576Citations
N/AReaders
Get full text

GAMMA-HYDROXYBUTYRIC ACID FOR TREATMENT OF ALCOHOL WITHDRAWAL SYNDROME

265Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The γ-hydroxybutyrate signalling system in brain: Organization and functional implications

422Citations
N/AReaders
Get full text

GHB: A new and novel drug of abuse

303Citations
N/AReaders
Get full text

Gamma-hydroxybutyrate: An emerging drug of abuse that causes physical dependence

265Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Gallimberti, L., Cibin, M., Pagnin, P., Sabbion, R., Pani, P. P., Pirastu, R., … Gessa, G. L. (1993). Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology, 9(1), 77–81. https://doi.org/10.1038/npp.1993.45

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

68%

Professor / Associate Prof. 3

16%

Researcher 3

16%

Readers' Discipline

Tooltip

Medicine and Dentistry 10

56%

Chemistry 3

17%

Agricultural and Biological Sciences 3

17%

Pharmacology, Toxicology and Pharmaceut... 2

11%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free